Skip to main content
SpringerLink
Log in
Book cover

Clinical PET-CT in Radiology pp 387–395Cite as

PET-CT of Renal Cell Carcinoma

  • Chapter
  • First Online:

  • 2192 Accesses

Abstract

There is a paucity of studies looking at the role of combined PET-CT in the evaluation of primary renal masses, staging and restaging of patients with renal cell carcinomas. However, given the preliminary evidence from the individual modalities, possible roles of PET-CT would include staging and restaging of selected patients with renal cell.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.

    Article  PubMed  Google Scholar 

  2. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006;176:2353–2358.

    Article  PubMed  Google Scholar 

  3. Rini BI, Rathmell WK, Godley P. Renal cell carcinoma. Curr Opin Oncol 2008;20:300–306.

    Article  PubMed  Google Scholar 

  4. Smith SJ, Bosniak MA, Megibow AJ, Hulnick DH, Horii SC, Raghavendra BN. Renal cell carcinoma: earlier discovery and increased detection. Radiology 1989;170:699–703.

    CAS  PubMed  Google Scholar 

  5. Janzen NK, Kim HL, Figlin RA, Belldegrun AS. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003;30:843–852.

    Article  PubMed  Google Scholar 

  6. Bosniak MA. The current radiological approach to renal cysts. Radiology 1986;158:1–10.

    CAS  PubMed  Google Scholar 

  7. Wolf JS, Jr. Evaluation and management of solid and cystic renal masses. J Urol 1998;159:1120–1133.

    Google Scholar 

  8. Goldberg MA, Mayo-Smith WW, Papanicolaou N, Fischman AJ, Lee MJ. FDG PET characterization of renal masses: preliminary experience. Clin Radiol 1997;52:510–515.

    Article  CAS  PubMed  Google Scholar 

  9. Kang DE, White RL, Jr., Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004;171:1806–1809.

    Article  PubMed  Google Scholar 

  10. S, Thomas GW, Berlangieri SU, et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001;166:825–830.

    Article  CAS  PubMed  Google Scholar 

  11. Shreve PD, Miyauchi T, Wahl RL. Characterization of primary renal cell carcinoma by FDG PET. Radiology 1998;209P:94.

    Google Scholar 

  12. I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 2005;173:1889–1892.

    Article  PubMed  Google Scholar 

  13. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655–663.

    Article  CAS  PubMed  Google Scholar 

  14. Mekhail TM, Abou-Jawde RM, Boumerhi G, et al. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol 2005;23:832–841.

    Article  PubMed  Google Scholar 

  15. Shuch B, La Rochelle JC, Pantuck AJ, Belldegrun AS. The staging of renal cell carcinoma. Curr Opin Urol 2008;18:455–461.

    Article  PubMed  Google Scholar 

  16. Aide N, Cappele O, Bottet P, et al. Efficiency of [(18)F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 2003;30:1236–1245.

    Article  PubMed  Google Scholar 

  17. Majhail NS, Urbain JL, Albani JM, et al. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma. J Clin Oncol 2003;21:3995–4000.

    Article  PubMed  Google Scholar 

  18. Jadvar H, Kherbache HM, Pinski JK, Conti PS. Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma. Clin Nephrol 2003;60:395–400.

    CAS  PubMed  Google Scholar 

  19. Seto E, Segall GM, Terris MK. Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan. Urology 2000;55:286.

    Article  CAS  PubMed  Google Scholar 

  20. Safaei A, Figlin R, Hoh CK, et al. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol 2002;57:56–62.

    CAS  PubMed  Google Scholar 

Further Reading

  1. Cohen HT, McGovern FJ. Renal-cell carcinoma. NEJM 2005;353:2477–2490.

    Google Scholar 

  2. Federle MP, Chen, J.J. Renal cell carcinoma. In: Federle MP (ed.). Diagnostic Imaging: Abdomen. Salt Lake City: Amirsys, 2004:III-3–96.

    Google Scholar 

  3. Hain SF, Maisey MN. Positron emission tomography for urological tumours. BJU Int 2003;92(2):159–164.

    Article  CAS  PubMed  Google Scholar 

  4. Shreve P. PET imaging in urologic tumors. In: Valk PE Bailey DL, Townsend DW, Maisey MN (eds.). Positron Emission Tomography: Basic Science and Clinical Practice Part IV: Oncology. London: Springer, 2003:637–644.

    Google Scholar 

  5. Shvarts O, Han KR, Seltzer M, Pantuck AJ, Belldegrun AS. Positron emission tomography in urologic oncology. Cancer Control 2002;9(4):335–342.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. FRG Molecular Imaging, Foundation Radiology Group, 401 Liberty Avenue, Suite 2000, Pittsburgh, PA, 15222, USA

    Todd M. Blodgett

Authors
  1. Todd M. Blodgett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanjay Paidisetty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Todd M. Blodgett .

Editor information

Editors and Affiliations

  1. Advanced Radiology Services, North Evergreen Drive 3264, Grand Rapids, 49525, Michigan, USA

    Paul Shreve

  2. , Head, PET and SPECT Development, Singapore Bioimaging Consortium, 11 Biopolis Way #02-02 Hel, Singapore, 138667, Singapur, Singapore

    David W. Townsend

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Blodgett, T.M., Paidisetty, S. (2011). PET-CT of Renal Cell Carcinoma. In: Shreve, P., Townsend, D. (eds) Clinical PET-CT in Radiology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-48902-5_29

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-48902-5_29

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-48900-1

  • Online ISBN: 978-0-387-48902-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation